Competitive inhibition by danazol of progesterone and dihydrotestosterone binding to human uterine progestin and androgen receptors.
D001667:Binding, Competitive; D003613:Danazol / Q000494:pharmacology*; D013196:Dihydrotestosterone / Q000378:metabolism; D004717:Endometrium / Q000166:cytology; D005260:Female; D006801:Humans; D011245:Pregnadienes / Q000494:pharmacology*; D011944:Receptors, Androgen / Q000187:drug effects*; D011980:Receptors, Progesterone / Q000187:drug effects*; D011987:Receptors, Steroid / Q000187:drug effects*; D014599:Uterus / Q000166:cytology*
D011245:Pregnadienes; D011944:Receptors, Androgen; D011980:Receptors, Progesterone; D011987:Receptors, Steroid; D013196:Dihydrotestosterone; D003613:Danazol